CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $27,217 | -94.1% | 594 | -93.7% | 0.00% | -100.0% |
Q3 2022 | $460,000 | -30.4% | 9,490 | -43.6% | 0.00% | -25.0% |
Q2 2022 | $661,000 | +393.3% | 16,823 | +363.8% | 0.00% | +300.0% |
Q1 2022 | $134,000 | -97.2% | 3,627 | -96.6% | 0.00% | -97.8% |
Q4 2021 | $4,825,000 | +143.2% | 105,851 | +90.6% | 0.05% | +84.0% |
Q3 2021 | $1,984,000 | +124.7% | 55,524 | +24.4% | 0.02% | +150.0% |
Q2 2021 | $883,000 | -53.5% | 44,619 | -45.3% | 0.01% | -58.3% |
Q1 2021 | $1,899,000 | +821.8% | 81,635 | +722.9% | 0.02% | +700.0% |
Q4 2020 | $206,000 | -39.6% | 9,921 | -37.0% | 0.00% | -40.0% |
Q3 2020 | $341,000 | -72.0% | 15,754 | -69.5% | 0.01% | -76.2% |
Q2 2020 | $1,218,000 | +1332.9% | 51,681 | +616.1% | 0.02% | +950.0% |
Q1 2020 | $85,000 | +157.6% | 7,217 | +133.0% | 0.00% | +100.0% |
Q4 2019 | $33,000 | -82.4% | 3,098 | -81.2% | 0.00% | -75.0% |
Q3 2019 | $188,000 | -46.0% | 16,517 | -46.6% | 0.00% | -33.3% |
Q2 2019 | $348,000 | +376.7% | 30,934 | +204.4% | 0.01% | +50.0% |
Q1 2018 | $73,000 | – | 10,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |